EP Patent

EP1474163A2 — Modification of feeding behavior

Assigned to Ip2ipo Innovations Ltd · Expires 2004-11-10 · 22y expired

What this patent protects

Methods are disclosed for decreasing calorie intake, food intake, and appetite in a subject. The methods include peripherally administering PYY or an agonist thereof and GLP-1 or an agonist thereof to the subject, simultaneously or sequentially, thereby decreasing the calorie int…

USPTO Abstract

Methods are disclosed for decreasing calorie intake, food intake, and appetite in a subject. The methods include peripherally administering PYY or an agonist thereof and GLP-1 or an agonist thereof to the subject, simultaneously or sequentially, thereby decreasing the calorie intake of the subject.

Drugs covered by this patent

Patent Metadata

Patent number
EP1474163A2
Jurisdiction
EP
Classification
—
Expires
2004-11-10
Drug substance claim
No
Drug product claim
No
Assignee
Ip2ipo Innovations Ltd
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.